Iqvia Q2 2018 earnings exceed expectations, CEO touts 'significant investments'
Iqvia recently announced its second quarter 2018 results, which came in “above the high end” of the company’s expectations at $2.567bn, said CEO Ari Bousbib.
Iqvia recently announced its second quarter 2018 results, which came in “above the high end” of the company’s expectations at $2.567bn, said CEO Ari Bousbib.
Hadassah Medical Center is joining the TriNetX global health research network to increase its clinical trial activity through collaboration.
PSI CRO’s new office in Bangalore, India joins the company’s 50 locations across five continents.
Repeal of the hotly debated medical device tax would free up research and development resources and bring clinical trials back to the US, say CRO industry executives.
NEWS IN BRIEF
Novo Nordisk announced a distribution agreement that will see quats delivered by Signet to the healthcare industry in India, as well as Bangladesh and Sri Lanka.
Researchers have suggested that the prescription of fast-acting fentanyl products were not appropriately reviewed by the FDA.
Frenova has added a fifth clinical research site to its site management organization and F1RST Up alliance.
LEO Pharma acquires Bayer’s prescription dermatology unit in a definitive agreement, in hopes of reaching their goal of being the leading global dermatology company by 2025.